Riskpilot← Back to searchSign inGet full accessSpecula Oy
OYActiveY-tunnus 2546291-4Sorsatie 29-D12Medical specialists activities · NACE 8622Est. 2013— employees
Revenue 2025
EUR 315K
+17% vs 2024
EBITDA margin
52.0%
+39% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
EUR 137K
-3% vs 2024
| Revenue | EUR 315K | +17% |
| EBITDA | EUR 164K | +39% |
| Net profit | EUR 137K | -3% |
| Total assets | EUR 954K | +6% |
| Equity | EUR 948K | +8% |
| Employees | — | — |
Legal name
Specula Oy
Y-tunnus number
2546291-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
25. huhtikuuta 2013
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäriasemat, yksityislääkärit ja vastaavat erikoislääkäripalvelut ja terveydenhuollon alan konsultointi. Yhtiö voi ostaa ja myydä sekä vuokrata ja antaa vuokralle kiinteää omaisuutta, sekä omistaa, myydä ja hallita osakkeita ja muita arvopapereita.
Address
Sorsatie 29-D12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 359 | 539 | 333 | 269 | 315 |
| Staff expenses | −117 | −122 | −66 | −63 | −65 |
| EBITDA | 155 | 292 | 181 | 118 | 164 |
| Depreciation & amort. | −17 | −24 | −19 | −31 | −9 |
| EBIT | 138 | 268 | 163 | 87 | 155 |
| Net financials | 37 | −43 | −22 | 80 | 16 |
| Profit before tax | 175 | 224 | 141 | 167 | 171 |
| Tax | 31 | 57 | 35 | 26 | 34 |
| Net profit | 144 | 168 | 106 | 141 | 137 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 750 | 855 | 870 | 896 | 954 |
| Equity | 637 | 759 | 805 | 881 | 948 |
| Long-term debt | 69 | 47 | 34 | 2 | 2 |
| Short-term debt | 43 | 49 | 31 | 13 | 4 |
| Total debt | 113 | 96 | 65 | 15 | 6 |
EBITDA margin
52.0%
This company
15.8%
Market median
+229% vs market
20212025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
14.4%
This company
18.4%
Market median
+22% vs market
20212025
Net profit margin
43.5%
This company
8.1%
Market median
+437% vs market
20212025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-10-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MT Chief Executive Officer | Chief Executive Officer | 2015 |
MO Audit | Audit | 2013 |
| Former (1) | ||
SS Deputy auditor | Deputy auditor | 2013 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Specula Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Taneli Malmivaara | Chief Executive Officer | 0 companies |
| Sami Seppo Sakari Posti | Deputy auditor | 0 companies |
| Mikko Olavi Virtanen | Audit | 0 companies |
| Anu Elina Urjanheimo | Board of Directors | 0 companies |